Glyco Genesys

GlycoGenesys is not "Atkins friendly" -- it's a big fan of carbs. The development-stage biotechnology company is working on carbohydrate-based drug candidates. Its product pipeline includes lead drug candidate GCS-100, a complex-carbohydrate glycoprotein. The company is testing GCS-100 as a possible treatment for various cancers, including pancreatic and colorectal cancer. The company stopped...